Abstract
We present a case of an elderly man with coronary artery disease who was diagnosed with non-Hodgkin lymphoma. Soon after the administration of chemotherapy, which included rituximab and vincristine, he developed acute myocardial infarction with cardiogenic shock. The condition was managed successfully with primary percutaneous coronary intervention. We briefly discuss the possible pathogenic mechanisms of chemotherapyinduced ischemic syndrome and the management of chemotherapy in patients with high cardiovascular risk.
| Original language | English |
|---|---|
| Pages (from-to) | 80-82 |
| Number of pages | 3 |
| Journal | Texas Heart Institute Journal |
| Volume | 41 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2014 |
| Externally published | Yes |
Keywords
- Acute coronary syndrome/chemically induced
- Acute myocardial infarction/chemically induced
- Antineoplastic agents/toxicity
- Cardiotoxins
- Endothelium
- Lymphoma
- Non-hodgkin
- Percutaneous coronary intervention
- Rituximab/adverse effects
- Tubulin/metabolism
- Vascular/drug effects
- Vincristine/adverse effects